Fluzoparib and Abiraterone in the preSurgery Treatment of Prostate Cancer: FAST Trial
Latest Information Update: 09 Jan 2025
At a glance
- Drugs Abiraterone acetate (Primary) ; Fuzuloparib (Primary) ; Prednisone
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- Acronyms FAST; FAST PC
- 02 Dec 2023 Planned End Date changed from 1 May 2023 to 1 Dec 2023.
- 02 Dec 2023 Planned primary completion date changed from 1 May 2023 to 1 Dec 2023.
- 02 Dec 2023 Status changed from recruiting to active, no longer recruiting.